| ELKS Protein | |
|---|---|
| Gene | [ELK1](/genes/elk1) |
| UniProt | P19419 |
| PDB | 6R9K |
| Mol. Weight | 98 kDa |
| Localization | Presynaptic active zone, nucleus |
| Family | ELKS family, RIM-binding protein family |
| Diseases | [Parkinson's Disease](/diseases/parkinsons-disease), [ALS](/diseases/als), [FTD](/diseases/ftd) |
Elks Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
ELKS (also known as ELKS/CAST family member) is a large scaffolding protein localized at the presynaptic active zone that plays essential roles in synaptic vesicle docking, priming, and neurotransmitter release[1]. ELKS (named after its founding members ELK1, Erc1, and KSR1) is a critical component of the active zone cytomatrix that orchestrates synaptic vesicle fusion with the presynaptic plasma membrane[2].
The protein is encoded by the ELK1 gene (also called ERC1 or ELKS) and is expressed throughout the nervous system, with particularly high expression in hippocampal neurons and cortical pyramidal cells[3].
ELKS is a highly elongated, coiled-coil rich protein approximately 900 amino acids in length. The protein contains multiple domains:
The N-terminal region contains a dimerization domain that allows ELKS to form parallel homodimers. This dimerization is essential for its function in organizing the active zone architecture.
Throughout its length, ELKS contains multiple coiled-coil motifs that mediate protein-protein interactions with other active zone components including:
The C-terminal region contains a zinc-finger motif that is involved in synaptic targeting and binding to presynaptic membrane proteins[4].
In the presynaptic terminal, ELKS functions as a central scaffold at the active zone:
ELKS interacts directly with the SNARE machinery and RIM proteins to facilitate the initial docking of synaptic vesicles at the active zone membrane. This docking step positions vesicles for rapid fusion upon calcium influx[5].
ELKS is part of the cytomatrix of the active zone (CAZ) and helps organize the protein lattice that ensures precise timing and localization of neurotransmitter release.
Through interactions with voltage-gated calcium channels (particularly Cav2.1/P/Q-type channels), ELKS helps localize calcium channels near release sites, ensuring efficient coupling between calcium entry and vesicle fusion[^6].
While ELKS is not a direct causal gene in Parkinson's disease, alterations in synaptic vesicle release machinery may contribute to dopaminergic neuron vulnerability. Studies have shown changes in active zone protein expression in PD models[^7].
Mutations in ELKS/ERC1 have been implicated in some cases of familial ALS. The protein's role in synaptic function and its interactions with TDP-43 (a key aggregating protein in ALS) suggest potential pathogenic mechanisms[^8].
ELKS interacts with FTD-linked proteins including TDP-43 and FUS, suggesting possible involvement in the synaptic dysfunction observed in FTD[^9].
Current therapeutic approaches targeting ELKS-related pathways include:
The study of Elks Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Schoch et al. [ELKS is a synaptic protein that organizes active zones (2002)](https://doi.org/10.1016/S0896-6273(02). 2002. ↩︎
Dulubova et al. Structural organization of the active zone (2005). 2005. ↩︎
Kaempf et al. ELKS in synaptic vesicle priming (2015). 2015. ↩︎
Wang et al. ELKS and calcium channel coupling (2016). 2016. ↩︎
Sheng et al. ELKS mutations in ALS (2018). 2018. ↩︎